| Risperdal Consta (risperidone depot formulation) / J&J |
NCT00261430: A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone. |
|
|
| Completed | 4 | 650 | US | GAIN Acceptance Approach | Janssen, LP | Schizophrenia | | 10/04 | | |
NCT00215579: Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence |
|
|
| Completed | 4 | 64 | US | Depot Risperidone Microsphere (Consta) | Duke University, Janssen, LP | Schizophrenia, Schizoaffective Disorder | 04/06 | 04/06 | | |
NCT00314613: Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal |
|
|
| Terminated | 4 | 30 | US | Antipsychotic/Risperidone Consta | Duke University, Janssen, LP | Schizophrenia | 12/06 | | | |
NCT00216528: A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres |
|
|
| Completed | 4 | 527 | RoW | risperidone | Janssen Korea, Ltd., Korea | Schizophrenia | | 04/07 | | |
NCT00216632: A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™) |
|
|
| Completed | 4 | 99 | Europe | risperidone | Janssen Pharmaceutica N.V., Belgium | Schizophrenia, Psychotic Disorders | 07/07 | 07/07 | | |
NCT00369239: Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis |
|
|
| Completed | 4 | 303 | Europe | risperidone long acting injectable | Janssen Pharmaceutica N.V., Belgium | Schizophrenia, Psychotic Disorders, Schizoaffective Disorder | | 11/07 | | |
NCT00313391: Risperdal Consta and Health Care Utilization in Patients With Schizophrenia |
|
|
| Completed | 4 | | US | Risperdal Consta | Emory University, Janssen, L.P. - Investigator Initiated Studies Program | Schizophrenia, Schizoaffective Disorder | 12/07 | | | |
NCT01726335: Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia |
|
|
| Completed | 4 | 53 | RoW | Risperidone prolonged release, - Risperdal consta | Janssen-Cilag Ltd. | Schizophrenia | 03/08 | 03/08 | | |
NCT00246259: A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis |
|
|
| Completed | 4 | 77 | Canada | Risperidone long-acting injection (LAI), Oral Antipsychotic | Janssen-Ortho Inc., Canada | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychotic Disorders | 12/08 | 12/08 | | |
NCT00299702: Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia |
|
|
| Completed | 4 | 355 | US | Abilify, Risperidal Consta | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Janssen, LP | Schizophrenia, Psychotic Disorders | 01/09 | 01/09 | | |
NCT00526877: An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment |
|
|
| Completed | 4 | 31 | RoW | Risperidone, Risperdal Consta | Johnson & Johnson Taiwan Ltd | Schizophrenia, Schizoaffective Disorders | 01/09 | 01/09 | | |
NCT01855074: An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders |
|
|
| Completed | 4 | 80 | RoW | Risperidone | Janssen-Cilag Ltd. | Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder | 02/09 | 02/09 | | |
| Completed | 4 | 219 | US | Risperidone, Risperdal, Risperdal Consta, Olanzapine, Zyprexa, Ziprasidone, Geodon, Quetiapine, Seroquel, Aripiprazole, Abilify | Icahn School of Medicine at Mount Sinai, National Institute of Mental Health (NIMH) | Schizophrenia | 03/09 | 03/09 | | |
NCT00256997 / 2005-004383-23: A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication |
|
|
| Terminated | 4 | 167 | Canada, Europe, RoW | Risperidone long-acting injection (LAI), Oral atypical Antipsychotic | Janssen-Ortho Inc., Canada | Schizophrenia | 04/09 | 04/09 | | |
NCT00216671: Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode |
|
|
| Completed | 4 | 220 | Europe, RoW | early initiation of treatment with Risperdal Consta, routine initiation of treatment with Risperdal Consta | Janssen Pharmaceutica N.V., Belgium | Schizophrenia | 12/09 | 12/09 | | |
NCT00378092 / 2015-001221-16: A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode |
|
|
| Completed | 4 | 33 | RoW | Oral risperidone, Risperidone Long-Acting Injection (RLAI), Risperdal consta | Janssen Cilag N.V./S.A. | Schizophrenia | 03/10 | 03/10 | | |
NCT00992407: An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective Disorder |
|
|
| Completed | 4 | 75 | RoW | Risperidone long acting injectables, Risperdal Consta, Risperidone tablets, Risperdal | Janssen Korea, Ltd., Korea | Schizophrenia | 12/10 | 12/10 | | |
PROACTIVE, NCT00330863: Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy |
|
|
| Completed | 4 | 357 | US | Risperidone microspheres, Risperdal Consta, Risperidone, Risperdal, Olanzapine, Zyprexa, Quetiapine, Seroquel, Ziprasidone, Geodon, Aripiprazole, Abilify, Paliperidone, Invega | Northwell Health, National Institute of Mental Health (NIMH) | Schizophrenia, Schizoaffective Disorder | 01/11 | 01/11 | | |
NCT00975611: Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation |
|
|
| Terminated | 4 | 6 | US | Amantadine Hydrochloride, USP, Symmetrel, Placebo, Symmetrel placebo | David C. Henderson, MD, Ortho-McNeil Janssen Scientific Affairs, LLC | Schizophrenia, Schizoaffective Disorder | 01/12 | 01/12 | | |
| Terminated | 4 | 1 | US | long-acting injectable risperidone, Risperdal (oral) & Risperdal Consta | Northwell Health, The Zucker Hillside Hospital, National Alliance for Research on Schizophrenia and Depression | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychotic Disorder Not Otherwise Specified | 11/13 | 11/13 | | |
